Tag: clinical study
-
Upadacitinib Maintains 1-Year Benefit for Pediatric IBD: New Findings from a Single-Center Study
Overview New findings presented from a single-center retrospective study suggest that upadacitinib (Rinvoq), a JAK1 inhibitor, provides durable clinical benefit over a 12-month period for children and adolescents with inflammatory bowel disease (IBD). The study, conducted in a pediatric population with Crohn’s disease (CD) or ulcerative colitis (UC), underscores the potential of targeted therapy to…
-
Regular ADAMTS13 Prophylaxis Reduces Acute Events and Organ Damage in cTTP
Key Finding: Prophylaxis Lowers Acute Events in cTTP A new long‑term analysis from the UK TTP Registry, published in Blood, highlights a clear benefit of regular ADAMTS13 prophylaxis for individuals with congenital thrombotic thrombocytopenic purpura (cTTP). The study follows patients over extended periods, comparing those who receive ongoing ADAMTS13 replacement therapy with those who are…
-
Nestlé Health Science Launches Landmark Study to Uncover the Impact of Lifestyle on Gut Health
Overview of the groundbreaking study Nestlé Health Science, a global leader in nutrition research, announced the launch of a landmark longitudinal study designed to uncover how lifestyle factors—chiefly dietary fiber—shape the human gut microbiome. The study aims to illuminate how daily choices related to diet, physical activity, sleep, and stress management influence gut health over…
-
AHN Study Finds Pelvic Floor Therapy Adherence Higher in Overactive Bladder Patients Not on Prescription Medications
New Insights from AHN’s Pelvic Health Research A retrospective study from Allegheny Health Network’s (AHN) Women’s Institute, published in the International Urogynecology Journal (DOI: 10.1007/s00192-025-06209-8), reveals a notable pattern in how patients with overactive bladder (OAB) engage with pelvic floor physical therapy (PFPT). The analysis found that OAB patients who were not concurrently prescribed other…
-
Canada’s Largest Cancer Centre to Offer Genomic Testing to All Patients in Five-Year Study
Groundbreaking five-year study to offer genomic testing to all patients In a major advance for personalized cancer care, Canada’s Princess Margaret Cancer Centre in Toronto announced a comprehensive plan to offer genomic testing to every patient treated at the facility over the next five years. The initiative aims to uncover hereditary health risks hidden in…
-
Rising Diverticulitis in Americans Under 50: What the Study Means
Summary: A Disturbing Trend A growing number of Americans under 50 are being diagnosed with diverticulitis, a painful gut condition once thought to affect mainly older adults. A collaborative study from leading institutions highlighted a marked uptick in hospitalizations for diverticulitis among younger adults, signaling a shift in who bears the burden of this digestive…
-
Preventing Skin Cancer With a Specific Supplement
Overview: Can a supplement aid skin cancer prevention? Skin cancer remains a rising global health concern, underscoring the importance of preventive strategies beyond daily sun protection. A recent study highlighted in JAMA Dermatology (September 2025) examined whether a specific dietary supplement could influence the likelihood of developing skin cancer. While the findings are intriguing, they…
